Live feed16:05:00·666dPRReleasevia QuantisnowAmneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 AgonistByQuantisnow·Wall Street's wire, on your screen.AMRX· Amneal Pharmaceuticals Inc.Health Care
